Immunotherapy for HIV-associated non-Hodgkin's lymphoma. - Wikidata - wikimedia - TriplyDB

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q37567836

about

The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.

P2860

Q47563526-5A60DF98-D23D-44A5-A1CE-2B6E8E8D5404

P2860

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q37567836

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

@en

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

@nl

type

label

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

@en

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

@nl

prefLabel

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

@en

Immunotherapy for HIV-associated non-Hodgkin's lymphoma.

@nl

P1433

Q37567836-874E3200-D5F9-4A0E-AA6F-AAD0A8811352

P1476

Q37567836-D2804316-3F73-495D-AA1B-EDE47D7F7D75

P2093

Q37567836-21E4C224-5393-4D8C-8544-E933E9EBA215

Q37567836-A4C1550E-98FA-4C93-9B5D-78444E344976

P2860

Q37567836-023D7ADD-21C3-4937-988A-891442349A2C

Q37567836-04421BA2-A652-4A65-A3A4-CF172E758666

Q37567836-10781BBD-B526-4F79-B1A2-79367E5ECF49

Q37567836-114D30AC-E36A-475B-BBA7-020D08B426B9

Q37567836-16D87222-2100-42E1-BCE0-8426AE872FF5

Q37567836-1FB53C53-F0DC-4F2E-9807-DEF5EA7A3D1F

Q37567836-2102A715-F5D3-45E3-87F1-5E8FFA071168

Q37567836-23066B83-75AB-4B6F-A7E1-A27E7B3F2FB7

Q37567836-23A01EF3-90CA-4CD7-8B2B-E9EB2659AAE6

Q37567836-2ACE3862-54CE-4504-AEE2-3DA6C1406710

P304

Q37567836-1B7749FF-3CF8-4EF7-8669-4C0ED16D0C3B

P31

Q37567836-B06ACA4F-C066-4888-AEE3-44CC600B2EAA

P356

Q37567836-154EF249-A46F-49BC-9664-5471AC745624

P407

Q37567836-3C039D2E-D549-41D5-B683-82409765A19E

P433

Q37567836-953953B5-8A30-4788-88BD-188D66FDA8B4

P478

Q37567836-5E1BB8AD-4EAD-48F4-85F0-6E43B5CA38A9

P50

Q37567836-168E6E32-405E-476E-8C57-3B1A3A38364F

P577

Q37567836-7E3FD166-B791-4FAC-81D5-5EB525517362

P698

Q37567836-AB872552-540F-48D8-8437-4254884D456F

P921

Q37567836-5E7A2507-D885-4DA1-8238-04CD02852DD7

P356

14712590903183516

P1433

Expert Opinion on Biological Therapy

P1476

Immunotherapy for HIV-associated non-Hodgkin's lymphoma

@en

P2093

Eliyaz Ahamed

http://www.w3.org/2001/XMLSchema#string

Thomas Newsom-Davis

http://www.w3.org/2001/XMLSchema#string

P2860

A new era for cancer immunotherapy based on the genes that encode cancer antigens

Cancer immunoediting: from immunosurveillance to tumor escape

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.

Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens.

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.

P304

1313-1324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712590903183516

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19645631

http://www.w3.org/2001/XMLSchema#string

P921